{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:13:25Z","timestamp":1784931205880,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"DOI":"10.7759\/cureus.113325","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:00:16Z","timestamp":1784930416000},"source":"Crossref","is-referenced-by-count":0,"title":["Delayed Arteriovenous Fistula Maturation Associated With an Ipsilateral Transvenous Implantable Cardioverter Defibrillator (ICD) Lead and Suspected Functional Hemodynamic Obstruction"],"prefix":"10.7759","author":[{"given":"Vickram","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update","volume":"75","author":"Lok CE","year":"2020","unstructured":"Lok CE, Huber TS, Lee T, et al.. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020, 75:S1-S164. 10.1053\/j.ajkd.2019.12.001","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016121355","article-title":"Intimal hyperplasia, stenosis, and arteriovenous fistula maturation failure in the hemodialysis fistula maturation study","volume":"28","author":"Cheung AK","year":"2017","unstructured":"Cheung AK, Imrey PB, Alpers CE, et al.. Intimal hyperplasia, stenosis, and arteriovenous fistula maturation failure in the hemodialysis fistula maturation study. J Am Soc Nephrol. 2017, 28:3005-13. 10.1681\/ASN.2016121355","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.05.081","article-title":"Implantable cardioverter defibrillator and resynchronization therapy in patients with overt chronic kidney disease: JACC state-of-the-art review","volume":"84","author":"Varga CR","year":"2024","unstructured":"Varga CR, Cleland JG, Abraham WT, Lip GY, Leyva F, Hatamizadeh P. Implantable cardioverter defibrillator and resynchronization therapy in patients with overt chronic kidney disease: JACC state-of-the-art review. J Am Coll Cardiol. 2024, 84:1342-62. 10.1016\/j.jacc.2024.05.081","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.017","article-title":"Lead-related venous obstruction in patients with implanted cardiac devices: JACC review topic of the week","volume":"79","author":"Zimetbaum P","year":"2022","unstructured":"Zimetbaum P, Carroll BJ, Locke AH, Secemsky E, Schermerhorn M. Lead-related venous obstruction in patients with implanted cardiac devices: JACC review topic of the week. J Am Coll Cardiol. 2022, 79:299-308. 10.1016\/j.jacc.2021.11.017","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cpf.12792","article-title":"How does a CIED presence influence chances and safety of haemodialysis access? Conclusions from over 3000 thoracic venografies","volume":"43","author":"Czajkowski M","year":"2023","unstructured":"Czajkowski M, Polewczyk A, Jache\u0107 W, Nowosielecka D, Tu\u0142ecki \u0141, Stefa\u0144czyk P, Kutarski A. How does a CIED presence influence chances and safety of haemodialysis access? Conclusions from over 3000 thoracic venografies. Clin Physiol Funct Imaging. 2023, 43:47-57. 10.1111\/cpf.12792","journal-title":"Clin Physiol Funct Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.12.029","article-title":"Secondary interventions in patients with implantable cardiac devices and ipsilateral arteriovenous access","volume":"70","author":"Dua A","year":"2019","unstructured":"Dua A, Rothenberg KA, Mikkineni K, Sgroi MD, Sorial E, Garcia-Toca M. Secondary interventions in patients with implantable cardiac devices and ipsilateral arteriovenous access. J Vasc Surg. 2019, 70:1242-6. 10.1016\/j.jvs.2018.12.029","journal-title":"J Vasc Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2022.01.020","article-title":"Pre-existing systolic dysfunction is the most powerful predictor of failed arteriovenous fistula maturation","volume":"87","author":"Faaborg-Andersen CC","year":"2022","unstructured":"Faaborg-Andersen CC, Ramos CR, Minton K, Benarroch-Gampel J, Teodorescu VJ, Rajani RR. Pre-existing systolic dysfunction is the most powerful predictor of failed arteriovenous fistula maturation. Ann Vasc Surg. 2022, 87:174-80. 10.1016\/j.avsg.2022.01.020","journal-title":"Ann Vasc Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00010.2025","article-title":"Cellular and molecular mechanisms underlying hemodialysis arteriovenous fistula dysfunction and approaches to promote maturation: a vascular perspective","volume":"329","author":"Shiu YT","year":"2025","unstructured":"Shiu YT, Northrup H, Huang Y, Cho ME, Bunsawat K. Cellular and molecular mechanisms underlying hemodialysis arteriovenous fistula dysfunction and approaches to promote maturation: a vascular perspective. Am J Physiol Heart Circ Physiol. 2025, 329:H241-57. 10.1152\/ajpheart.00010.2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145795","article-title":"The role of shear stress in arteriovenous fistula maturation and failure: a systematic review","volume":"10","author":"Browne LD","year":"2015","unstructured":"Browne LD, Bashar K, Griffin P, Kavanagh EG, Walsh SR, Walsh MT. The role of shear stress in arteriovenous fistula maturation and failure: a systematic review. PLoS One. 2015, 10:e0145795. 10.1371\/journal.pone.0145795","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057816","article-title":"Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in the PRAETORIAN trial","volume":"145","author":"Knops RE","year":"2022","unstructured":"Knops RE, van der Stuijt W, Delnoy PP, et al.. Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in the PRAETORIAN trial. Circulation. 2022, 145:321-9. 10.1161\/CIRCULATIONAHA.121.057816","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.125.074576","article-title":"Device-related complications in transvenous versus subcutaneous defibrillator therapy during long-term follow-up: the PRAETORIAN-XL trial","volume":"152","author":"Olde Nordkamp LR","year":"2025","unstructured":"Olde Nordkamp LR, de Veld JA, Ghani A, et al.. Device-related complications in transvenous versus subcutaneous defibrillator therapy during long-term follow-up: the PRAETORIAN-XL trial. Circulation. 2025, 152:172-82. 10.1161\/CIRCULATIONAHA.125.074576","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018, 72:e91-e220. 10.1016\/j.jacc.2017.10.054","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001187","article-title":"Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a scientific statement from the American Heart Association: endorsed by the International Society for Cardiovascular Infectious Diseases","volume":"149","author":"Baddour LM","year":"2024","unstructured":"Baddour LM, Esquer Garrigos Z, Rizwan Sohail M, et al.. Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a scientific statement from the American Heart Association: endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation. 2024, 149:e201-16. 10.1161\/CIR.0000000000001187","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.11.023","article-title":"ACC\/AHA\/ASE\/HFSA\/HRS\/SCAI\/SCCT\/SCMR 2025 appropriate use criteria for implantable cardioverter-defibrillators, cardiac resynchronization therapy, and pacing","volume":"85","author":"Russo AM","year":"2025","unstructured":"Russo AM, Desai MY, Do MM, et al.. ACC\/AHA\/ASE\/HFSA\/HRS\/SCAI\/SCCT\/SCMR 2025 appropriate use criteria for implantable cardioverter-defibrillators, cardiac resynchronization therapy, and pacing. J Am Coll Cardiol. 2025, 85:1213-85. 10.1016\/j.jacc.2024.11.023","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07920520","article-title":"Trends in use and in-hospital outcomes of subcutaneous implantable cardioverter defibrillators in patients undergoing long-term dialysis","volume":"15","author":"Pun PH","year":"2020","unstructured":"Pun PH, Parzynski CS, Friedman DJ, Sanders G, Curtis JP, Al-Khatib SM. Trends in use and in-hospital outcomes of subcutaneous implantable cardioverter defibrillators in patients undergoing long-term dialysis. Clin J Am Soc Nephrol. 2020, 15:1622-30. 10.2215\/CJN.07920520","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman P","year":"2022","unstructured":"Friedman P, Murgatroyd F, Boersma LV, et al.. Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N Engl J Med. 2022, 387:1292-302. 10.1056\/NEJMoa2206485","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505555-delayed-arteriovenous-fistula-maturation-associated-with-an-ipsilateral-transvenous-implantable-cardioverter-defibrillator-icd-lead-and-suspected-functional-hemodynamic-obstruction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:00:17Z","timestamp":1784930417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505555-delayed-arteriovenous-fistula-maturation-associated-with-an-ipsilateral-transvenous-implantable-cardioverter-defibrillator-icd-lead-and-suspected-functional-hemodynamic-obstruction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.113325","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}